These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24025378)
41. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Reechaipichitkul W Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593 [TBL] [Abstract][Full Text] [Related]
42. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009. Papaventsis D; Nikolaou S; Karabela S; Ioannidis P; Konstantinidou E; Marinou I; Sainti A; Kanavaki S Euro Surveill; 2010 Jul; 15(28):. PubMed ID: 20650053 [TBL] [Abstract][Full Text] [Related]
43. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy. Mehta J; Keith R; Al Hasan M; Ryland B; Roy T Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201 [TBL] [Abstract][Full Text] [Related]
44. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
45. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007. Bang D; Lillebaek T; Thomsen VØ; Andersen AB Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573 [TBL] [Abstract][Full Text] [Related]
46. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880 [TBL] [Abstract][Full Text] [Related]
47. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691 [TBL] [Abstract][Full Text] [Related]
48. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707 [TBL] [Abstract][Full Text] [Related]
49. Resistance to anti-tuberculosis medications in the Horn of Africa. Ollé-Goig JE; Codina-Grau G; Martín-Casabona N Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114 [TBL] [Abstract][Full Text] [Related]
50. Trends in the epidemiology of childhood tuberculosis in Greece. Syridou G; Mavrikou M; Amanatidou V; Spyridis N; Prasad P; Papaventsis D; Kanavaki S; Zaoutis T; Tsolia MN Int J Tuberc Lung Dis; 2012 Jun; 16(6):749-55. PubMed ID: 22507870 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Yoshiyama T; Supawitkul S; Kunyanone N; Riengthong D; Yanai H; Abe C; Ishikawa N; Akarasewi P; Payanandana V; Mori T Int J Tuberc Lung Dis; 2001 Jan; 5(1):32-9. PubMed ID: 11263513 [TBL] [Abstract][Full Text] [Related]
52. Risk factors for drug resistant tuberculosis in southeast Turkey. Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496 [TBL] [Abstract][Full Text] [Related]
53. Tuberculosis in Poland in 2017. Korzeniewska- Koseła M Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679 [TBL] [Abstract][Full Text] [Related]
54. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Feja K; McNelley E; Tran CS; Burzynski J; Saiman L Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183 [TBL] [Abstract][Full Text] [Related]
55. Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil. Ramalho DMP; Miranda PFC; Andrade MK; Brígido T; Dalcolmo MP; Mesquita E; Dias CF; Gambirasio AN; Ueleres Braga J; Detjen A; Phillips PPJ; Langley I; Fujiwara PI; Squire SB; Oliveira MM; Kritski AL; BMC Infect Dis; 2017 Aug; 17(1):571. PubMed ID: 28810911 [TBL] [Abstract][Full Text] [Related]
56. Increasing Prevalence of Pediatric Drug-resistant Tuberculosis in Mumbai, India, and Its Outcome. Shah MA; Shah I Pediatr Infect Dis J; 2018 Dec; 37(12):1261-1263. PubMed ID: 29596221 [TBL] [Abstract][Full Text] [Related]
57. Clinical profile of drug resistant tuberculosis in children. Shah I; Chilkar S Indian Pediatr; 2012 Sep; 49(9):741-4. PubMed ID: 22728624 [TBL] [Abstract][Full Text] [Related]
58. Drug Resistance in Children with Central Nervous System Tuberculosis from a Tertiary Care Center in Mumbai. Mane SS; Janardhanan J; Pustake M; Ali MK; Khan GI J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34918167 [TBL] [Abstract][Full Text] [Related]
59. Surveillance for tuberculosis in a rural community in The Philippines. Lopez AL; Aldaba JG; Ama CG; Sylim PG; Geraldino XD; Sarol JN; Salonga AM Int J Tuberc Lung Dis; 2016 Nov; 20(11):1495-1500. PubMed ID: 27776591 [TBL] [Abstract][Full Text] [Related]
60. Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations. Garcia-Prats AJ; Rose PC; Hesseling AC; Schaaf HS Tuberculosis (Edinb); 2014 Mar; 94(2):93-104. PubMed ID: 24388605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]